Valley Brook Capital Group, Inc. Amgen Inc Transaction History

Valley Brook Capital Group, Inc.

$133 Million
Q4 2024

A detailed history of Valley Brook Capital Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Valley Brook Capital Group, Inc. holds 4,564 shares of AMGN stock, worth $1.3 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

4,564

Previous 5,162 11.58%

Holding current value

$1.3 Million

Previous $1.66 Million 28.5%

% of portfolio

0.89%

Previous 1.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$258.78 - $328.31 $154,750 - $196,329	-598 Reduced 11.58%	4,564 $1.19 Million
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $4,021 - $4,385	-13 Reduced 0.25%	5,162 $1.66 Million
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $81,452 - $98,986	310 Added 6.37%	5,175 $1.62 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $36,297 - $43,815	135 Added 2.85%	4,865 $1.38 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $79,267 - $89,422	310 Added 7.01%	4,730 $1.36 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 3.51%	4,420 $1.19 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $57,852 - $68,409	-270 Reduced 5.95%	4,270 $948,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $22,579 - $27,520	-100 Reduced 2.16%	4,540 $1.1 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $4,580 - $5,820	20 Added 0.43%	4,640 $1.22 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $5,767 - $6,418	25 Added 0.54%	4,620 $1.12 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $57,010 - $63,068	260 Added 6.0%	4,595 $1.11 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $16,904 - $19,346	85 Added 2.0%	4,335 $975,000
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $37,147 - $43,522	-175 Reduced 3.95%	4,250 $903,000
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $26,160 - $29,023	112 Added 2.6%	4,425 $1.08 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $5,103 - $5,947	23 Added 0.54%	4,313 $1.07 Million
Q4 2020 Mar 19, 2021	BUY	$216.38 - $257.67 $928,270 - $1.11 Million	4,290 New	4,290 $986,000

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley Brook Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valley Brook Capital Group, Inc. with notifications on news.

Account

Valley Brook Capital Group, Inc. Amgen Inc Transaction History